CCEL Q3 2022 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q3 2022 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+2.4% YoY

Gross Profit

$5M69.4% margin

Operating Income

$1M17.8% margin

Net Income

$466,8206.1% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$9M

Stock-Based Comp.

$161,083

Balance Sheet

Total Assets

$67M

Total Liabilities

$69M

Stockholders' Equity

-$2M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+2.4%
Gross Profit	$5M	$5M	+5.7%
Operating Income	$1M	$2M	-14.3%
Net Income	$466,820	$856,494	-45.5%

Revenue Segments

Processing And Storage Fees

$8M98%

Public Banking

$137,8252%

Product

$21,0000%